[{"id":"kit","kind":"target","name":"KIT","route":"/targets/kit/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/targets.ts","type":"changed","fields":[{"field":"tldr","before":"\"KIT mutation is the driver behind most gastrointestinal stromal tumours, and the reason imatinib turned a lethal sarcoma into a chronic disease.\"","after":"\"KIT mutation is the driver behind most gastrointestinal stromal tumours, and the reason imatinib turned a sarcoma with a median survival of about a year into a chronic disease.\""}]},{"id":"kit","kind":"target","name":"KIT","route":"/targets/kit/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/targets.ts","type":"changed","fields":[{"field":"tldr","before":"\"The mutation behind most gastrointestinal stromal tumours, and the reason imatinib turned a lethal sarcoma into a chronic disease.\"","after":"\"KIT mutation is the driver behind most gastrointestinal stromal tumours, and the reason imatinib turned a lethal sarcoma into a chronic disease.\""}]},{"id":"kit","kind":"target","name":"KIT","route":"/targets/kit/","commit":"cebb34a709","date":"2026-09-08","author":"Jude Gomila","message":"Guideline mapping on every standard-of-care row; sourced biomarker prevalence for 59 targets; GuidelineChip, PrevalenceTable, CancerPrevalen","file":"src/data/targets.ts","type":"changed","fields":[{"field":"prevalence","after":"[\n      { cancerId: \"sarcoma\", pct: \"75-80\", measure: \"GIST KIT mutation\", source: \"https://en.wikipedia.org/wiki/CD117\", note: \"PDGFRA in ~10%\" },\n      { cancerId: \"melanoma\", pct: \"2-3\", measure: \"KIT mutation (acr..."}]}]